People suffering from heartburn or stomach ulcers take a high amount of widely prescribed drugs to neutralize stomach acid. But, a recent study of over 40,000 patients has shown that intake of these drugs could be associated with increased risk of kidney disease.
The study, published in the Scientific Reports journal, showed patients who took proton pump inhibitors (PPIs) were more likely to experience kidney disease than those who took another type of drug used to dampen down acid production called H2 blockers.
Heartburn Symptom Evaluation
Heartburn is a symptom that occurs due to irritation of the food pipe either due to acid reflux or direct contact with spicy and irritant foods.
Advertisement
‘Patients who took proton pump inhibitors (PPIs) are more likely to suffer from chronic kidney disease, acute kidney injury, end-stage renal disease or unspecified kidney impairment.’
Tweet it Now
The patients who took only PPIs were 28.4 times more likely to report chronic kidney disease, as well as acute kidney injury (4.2 times more likely), end-stage renal disease (35.5 times more likely) and unspecified kidney impairment (eight times more likely), said researchers including Ruben Abagyan, Professor from the University of California-San Diego.
According to the World Health Organisation, PPIs are essential medicines for many people, helping them to control symptoms that are often painful and disruptive to daily life.
![Top 10 Ways to Soothe Heartburn During Pregnancy]( "Top 10 Ways to Soothe Heartburn During Pregnancy")
Heartburn symptoms are common during the second and third trimester of pregnancy. Simple tips can help manage heartburn.
But Abagyan hopes this initial data will prompt healthcare providers to appropriately warn, educate and monitor patients who require PPIs, particularly if they are at an elevated risk for kidney disease and electrolyte abnormalities.
For the study, the team looked at a data of 43,000 patients who took PPIs and the control group, approximately 8,000 patients who took histamine-2 receptor blockers, such as Zantac or Pepcid, and no other medications.
Patients who took only PPIs reported a kidney-related adverse reaction at a frequency of 5.6 per cent against 0.7 per cent for patients who took only histamine-2 receptor antagonists.
However, the researchers cautioned the study does not reveal absolute frequency of these kidney-related complaints for all people taking PPIs. A large, randomized, controlled clinical trial would be needed to show causality between PPI usage and absolute risk of kidney disease in humans.
Source: IANS
Top 10 Ways to Soothe Heartburn During Pregnancy
Heartburn symptoms are common during the second and third trimester of pregnancy. Simple tips can help manage heartburn.
Advertisement
But Abagyan hopes this initial data will prompt healthcare providers to appropriately warn, educate and monitor patients who require PPIs, particularly if they are at an elevated risk for kidney disease and electrolyte abnormalities.
For the study, the team looked at a data of 43,000 patients who took PPIs and the control group, approximately 8,000 patients who took histamine-2 receptor blockers, such as Zantac or Pepcid, and no other medications.
Patients who took only PPIs reported a kidney-related adverse reaction at a frequency of 5.6 per cent against 0.7 per cent for patients who took only histamine-2 receptor antagonists.
However, the researchers cautioned the study does not reveal absolute frequency of these kidney-related complaints for all people taking PPIs. A large, randomized, controlled clinical trial would be needed to show causality between PPI usage and absolute risk of kidney disease in humans.
Source: IANS
Top Yoga Asanas to Relieve You from Heartburn
Yoga is a form of exercise and way of living that can not only prevent but also treat numerous conditions like heartburn effectively and safely.
Advertisement
 AcidityAcidity and dyspepsia is excessive acid production in the stomach causing heartburn and acid reflux. Excess HCL acid in stomach can be due to stress and spicy foods. | Advertisement
|
Advertisement
Recommended Reading
Latest Drug News
The CDSCO has approved the intravenous administration of AstraZeneca Pharma India's liver cancer drug, Tremelimumab Concentrate.
The FDA advises consumers not to use compounded medications as an alternative to known diabetic and weight reduction medications Ozempic, Rybelsus, and Wegovy.
Addressing the unmet needs of Parkinson's Disease by providing disease-modifying therapies could bring about a major shift in the way that patients are treated.
Microrobots could swirl through a person's blood stream, search for targeted areas to treat for various ailments.
Supplementation with multivitamins is an inexpensive way for older adults to slow down memory loss.